Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Genmab
Parabilis Medicines, Inc.
National Institutes of Health Clinical Center (CC)
Eikon Therapeutics
Genmab
Alliance Foundation Trials, LLC.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
Eisai Inc.
AstraZeneca
Terremoto Biosciences Inc.
GlaxoSmithKline
Artios Pharma Ltd
Ensem Therapeutics
Eisai Inc.
BioNTech SE
PMV Pharmaceuticals, Inc
Mayo Clinic
Qilu Pharmaceutical Co., Ltd.
Eli Lilly and Company
AstraZeneca
Genmab
Children's Oncology Group
AstraZeneca
Arvinas Inc.
Revolution Medicines, Inc.
GlaxoSmithKline
DualityBio Inc.
Beijing Tide Pharmaceutical Co., Ltd
Second Life Therapeutics
University of Chicago
Tanabe Pharma America, Inc.
Regeneron Pharmaceuticals
GV20 Therapeutics
Regeneron Pharmaceuticals
Avenzo Therapeutics, Inc.
Laekna Limited
Alaunos Therapeutics
Volastra Therapeutics, Inc.
Hospices Civils de Lyon
Sichuan Baili Pharmaceutical Co., Ltd.
Eli Lilly and Company
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Centre Leon Berard
Incyte Corporation
Incyte Corporation
Cancer Research UK
NuCana plc